THERALINK TECHNOLOGIES, INC. (OTC:THER)
Health Care/Life Sciences • Pharmaceuticals
CIK 1362703
Company
Theralink Technologies, Inc. is a precision medicine company, which engages in the development of novel cancer immunotherapy products. It offers the reverse phase protein array technology platform that can quantify protein signaling to support oncology clinical treatment decisions and biopharmaceutical drug development. The company was founded on March 18, 2005 and is headquartered in Golden, CO.
Address
15000 West 6th Avenue
Suite 400
Golden, Colorado 80401
15000 West 6th Avenue
Suite 400
Golden, Colorado 80401
Employees
16
16
Stock Info
Key Executives
Board Of Directors
Chairman Jeffrey Mark Busch |
Chief Financial Officer & Director Andrew Albert Kucharchuk MBA |
Chief Medical Officer & Director Michael I Ruxin MD |
Director Yvonne C Fors |
Independent Director Danica Holley |
Independent Director Matthew M Schwartz MD |
SEC filings
Date | Form | Event |
---|---|---|
15 May, 2024 | 15-12G | |
6 Mar, 2024 | 8-K | |
20 Feb, 2024 | 10-Q | |
15 Feb, 2024 | NT 10-Q | |
15 Feb, 2024 | 10-K/A | |
2 Feb, 2024 | 4 | |
26 Jan, 2024 | 4 | |
26 Jan, 2024 | 4 | |
5 Jan, 2024 | 10-K | |
29 Dec, 2023 | NT 10-K | |
19 Dec, 2023 | 3 | |
28 Nov, 2023 | 8-K | |
21 Aug, 2023 | 10-Q | |
15 Aug, 2023 | NT 10-Q | |
29 Jun, 2023 | 8-K | CEO Change |
26 May, 2023 | 8-K | |
26 May, 2023 | 425 | |
15 May, 2023 | 10-Q | |
11 May, 2023 | 8-K | CEO Change |
21 Feb, 2023 | 10-Q | |
15 Feb, 2023 | NT 10-Q | |
1 Feb, 2023 | 8-K | |
29 Dec, 2022 | 10-K | |
14 Dec, 2022 | D | |
9 Dec, 2022 | 8-K | |
1 Dec, 2022 | 8-K | |
26 Sep, 2022 | 4 | |
22 Sep, 2022 | 4 | |
21 Sep, 2022 | 4 | |
21 Sep, 2022 | 4 | |
21 Sep, 2022 | 4 | |
16 Sep, 2022 | 8-K | |
15 Aug, 2022 | 10-Q | |
12 Jul, 2022 | 8-K/A | |
7 Jul, 2022 | 8-K | |
22 Jun, 2022 | 4 | |
21 Jun, 2022 | 3 | |
2 Jun, 2022 | DEF 14C | |
23 May, 2022 | 10-Q | |
20 May, 2022 | PRE 14C | |
17 May, 2022 | NT 10-Q | |
6 Apr, 2022 | 8-K | |
5 Apr, 2022 | 3 | |
18 Feb, 2022 | 10-Q | |
15 Feb, 2022 | NT 10-Q | |
3 Feb, 2022 | 8-K | |
13 Jan, 2022 | 10-K | |
5 Jan, 2022 | 8-K | |
30 Dec, 2021 | NT 10-K | |
29 Nov, 2021 | 8-K | |
5 Nov, 2021 | 8-K | |
28 Sep, 2021 | 10-Q | |
27 Sep, 2021 | 10-Q | |
27 Sep, 2021 | 10-K | |
27 Sep, 2021 | 10-Q | |
6 Aug, 2021 | 8-K | |
11 Jun, 2021 | 10-Q | |
8 Jun, 2021 | 8-K | |
19 May, 2021 | 8-K | |
20 Apr, 2021 | 8-K/A | |
20 Apr, 2021 | 8-K | |
20 Apr, 2021 | 8-K | |
12 Feb, 2021 | D |
Last update:2024-03-06 12:29:07.126579
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.